In randomized controlled trials, there are two treatment solutions at the moment considered the normal of treatment in Guillain-Barré syndrome (GBS). These incorporate both intravenous immunoglobulin (IVIG) or plasma https://ksnr.org.in/guillain-barre-syndrome/